Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations

6 Jun 2015

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Neurological disorders and treatments
Share to Nuclear Receptors and Signaling
Share to Parkinson's Disease Mechanisms and Treatments

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 26050140
DOI: 10.1016/s1474-4422(15)00006-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerationsPMID 26050140Read ↗

The Central Theme of Parkinson’s Disease: α-SynucleinSemantic proximity Read ↗

The role of alpha-synuclein in Parkinson's disease: insights from animal models.Semantic proximity Read ↗

Alpha-synuclein and Parkinson's disease.Semantic proximity Read ↗

The good and bad of therapeutic strategies that directly target α‐synucleinSemantic proximity Read ↗

The role of α-synuclein in neurodegenerative diseasesSemantic proximity Read ↗

α-Synuclein and Mitochondrial Dysfunction in Parkinson’s DiseaseSemantic proximity Read ↗

α-Synuclein, Parkinson's disease, and Alzheimer's diseaseSemantic proximity Read ↗

α-Synuclein in Parkinson's Disease: Pathogenic Function and Translation into Animal ModelsSemantic proximity Read ↗

Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery.Semantic proximity Read ↗

Part II: α-synuclein and its molecular pathophysiological role in neurodegenerative diseaseSemantic proximity Read ↗

Alpha-Synuclein in Parkinson’s Disease: From Pathogenetic Dysfunction to Potential Clinical ApplicationSemantic proximity Read ↗

α-synuclein aggregation reduces nigral myocyte enhancer Factor-2D in idiopathic and experimental Parkinson's diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.